RYTM
Rhythm Pharmaceuticals Inc
92.50$
-0.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.7% | -2.9% | -3.7% | -1.3% | -0.5% | +0.0% | -1.0% | -19.8% | -10.5% | -7.4% | +99.6% | – | |
| – | +0.7% | -10.5% | +33.4% | +6.2% | -4.0% | +21.8% | +23.5% | +18.5% | +2.4% | +19.9% | +112.8% | – | |
| – | – | -124.6% | – | – | +117.1% | -177.5% | – | -31.3% | -122.2% | – | – | – | |
| – | +0.0% | +3,999,900.0% | -100.0% | – | -100.0% | – | – | – | – | -100.0% | – | – | |
| – | – | +32.7% | -128.5% | +960.7% | – | +17.3% | +117.8% | -555.9% | – | +88.0% | +24.6% | – | |
| – | – | – | – | – | – | – | – | -48.5% | -99.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -96.7% | +75.1% | +3,345.2% | -98.3% | +1,438.0% | -15.2% | -102.7% | – | -101.6% | +83.2% | +21.6% | – | |
| – | – | – | – | -205.5% | – | -59.3% | +74.3% | -382.1% | – | +252.5% | +45.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.